The attendee will be able to:
1.) Determine no less than two (2) ways to shorten Phase 1 studies through increased efficiencies in clinical supplies management
2.) Explain the reason why shortening phase I trials has become such a high priority in drug development
3.) Differentiate between standard Phase I clinical trial requirements and Fast Track Phase I clinical trial requirements